Pollock RF & Meckley LM. (2018). An evaluation of the budget impact of a new 20% subcutaneous immunoglobulin (Ig20Gly) for the management of primary immunodeficiency diseases in Switzerland. Dove Medical Press.
Chicago Style (17th ed.) CitationPollock RF and Meckley LM. An Evaluation of the Budget Impact of a New 20% Subcutaneous Immunoglobulin (Ig20Gly) for the Management of Primary Immunodeficiency Diseases in Switzerland. Dove Medical Press, 2018.
MLA (9th ed.) CitationPollock RF and Meckley LM. An Evaluation of the Budget Impact of a New 20% Subcutaneous Immunoglobulin (Ig20Gly) for the Management of Primary Immunodeficiency Diseases in Switzerland. Dove Medical Press, 2018.
Warning: These citations may not always be 100% accurate.